VaramirStart free · no cardSign in
VRDN as of Oct 31 · 05:31 ET
VRDNNasdaqPharmaceutical Preparations

Viridian Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±19.0%
avg realized
±9.3%
Nov 12 '24±6.6%▼−12.76%×1.94
Feb 27 '25±21.7%▼−1.55%×0.07
May 6 '25±32.4%▼−8.31%×0.26
Aug 6 '25±22.0%▼−1.38%×0.06
Nov 5 '25±18.1%▲+8.29%×0.46
Q1 FY26±24.8%▲+1.90%×0.08
May 5 '26±9.5%▲+33.36%×3.49
Q2 FY26±17.2%▲+6.83%×0.40
quarterimplied−35%0+35%realized×
Q2 FY26±17.2%▲+6.83%×0.40
May '26±9.5%▲+33.36%×3.49
Q1 FY26±24.8%▲+1.90%×0.08
Nov '25±18.1%▲+8.29%×0.46
Aug '25±22.0%▼−1.38%×0.06
May '25±32.4%▼−8.31%×0.26
2 older reports
Feb '25±21.7%▼−1.55%×0.07
Nov '24±6.6%▼−12.76%×1.94
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

10disclosed supplier and customer ties in SEC filingsSEC filings
217managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

6 of 8recent reports where the move came in under the options implied rangeEarnings history
4tracked funds holding VRDNN-PORT · Aug 31 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

VRDN report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±18.0% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.